| 000 | 01603 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515023328.0 | ||
| 264 | 0 | _c20060915 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2006.02888.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWong, C H | |
| 245 | 0 | 0 |
_aGastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cMay 2006 |
||
| 300 |
_a1321-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
| 650 | 0 | 4 |
_aAntacids _xtherapeutic use |
| 650 | 0 | 4 |
_aAsthma _xcomplications |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForced Expiratory Flow Rates |
| 650 | 0 | 4 |
_aForced Expiratory Volume _xdrug effects |
| 650 | 0 | 4 |
_aGastroesophageal Reflux _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLansoprazole |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmeprazole _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPeak Expiratory Flow Rate _xdrug effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aProton Pump Inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChua, C J | |
| 700 | 1 | _aLiam, C K | |
| 700 | 1 | _aGoh, K L | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 23 _gno. 9 _gp. 1321-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2006.02888.x _zAvailable from publisher's website |
| 999 |
_c16233866 _d16233866 |
||